Transcript adult stem cells????

•
•
•
•
•
•
•
•
•
scrotum = supportive structure for the
testes
consists of loose skin and superficial
fascia that hangs from the root of the
penis
externally- single pouch separated at
the midline by a raphe
internally – divided by a scrotal
septum into two sacs each containing
1 testis
the septum = dartos muscle (smooth
muscle) + superficial fascia
dartos is also found in the
subcutaneous portion of the scrotal
skin
each testis is associated with a
cremaster muscle – skeletal muscle
that is a continuation of the internal
oblique
exterior location of the testis ensures
its internal temperature is at least 2 to
3C lower than the body core
failure of the testes to descend =
cryptochidism
–
–
–
–
3% of full-term infants and 30% or
premature infants
untreated – results in sterility
increases the chances of testicular
cancer
80% of those undescended testes will
descend spontaneously within the year
-testis: develop internally near the kidneys and descend through the inguinal canal during the
latter half of the seventh month gestation
-covered by several protection membranes
1. tunica vaginalis – serous membrane derived from the peritoneum, forms during the descent
of the testes
-injury to the testes can cause an accumulation of fluid within the membrane =
hydrocele
-allows for easier movement of the testes within the scrotum
2. tunical albuginea – internal to the TV
-extends inward to divide the testes into lobules (200-300)
-each lobule contains 1 to 3 coiled seminiferous tubules for sperm production
-lined with epithelium that produce sperm (spermatogenic cells)
•
embedded among the spermatogenic cells of the seminiferous tubules – Sertoli cells
– sustenacular cells
– extend from the basement membrane of a seminiferous tubule to the lumen
– during the Maturation phase of spermiogenesis - Sertoli cells consume the unneeded portions of
the spermatazoa.
– once fully differentiated, the Sertoli cell is unable to proliferate
– adjacent cells are joined together by tight junctions – blood-testis barrier
– this barrier prevents an immune response against the spermatogenic cells’ surface antigens
which are recognized as they develop as being foreign
– this creates a privileged immune environment
– also secrete numerous cytokines and growth factors that mediate spermatogenesis
•
•
•
•
anti-Müllerian hormone (AMH) - secreted during the early stages of fetal life.
inhibin and activins - secreted after puberty, and work together to regulate FSH secretion
androgen binding protein - faciliate spermatogenesis and sperm maturation
glial cell line-derived neurotrophic factor (GDNF) - has been demonstrated to function in promoting
undifferentiating spermatogonia - ensures stem cell self-renewal
• the Ets related molecule (ERM transcription factor) - needed for maintenance of the spermatogonial
stem cell in the adult testis.
• transferrin
•
between adjacent seminiferous tubules are the interstitial cells or Leydig cells
–
–
–
–
for the production of testosterone (androgen)
can be a site for the development of testicular cancer - along with Sertoli cells
androgen = hormone for the development of masculine characteristics
Sertoli-Leydig tumor – type of ovarian tumor
• Arrhenoblastomas – Sertoli-Leydig cells within the ovary secrete androgens leading to virilization of
the female phenotype
Spermatogenesis
•
•
•
•
•
•
•
•
•
•
•
•
•
sperm development – from sperm stem cells called
spermatogonium
these spermatogonium develop in the embryonic
testes from primordial germ cells that arise from
the yolk sac
the spermatogonium remain dormant in the testes
until puberty
the maturing sperm can be found toward the lumen
of the seminiferous tubule
most mature = sperm cells or spermatozoa
takes 60-75 days to complete
1. dissociation of some spermatogonium from the
basemement membrane of the ST
2. differentiation of the dissociating spermatogonium
into primary spermatocytes (2n)
3. replication of DNA within the spermatocyte and
the onset of meiosis
4. formation of secondary spermatocytes (n) –
however despite having 23 chromosomes, these
chromosomes are still comprise of two chromatids
5. completion of meiosis and formation of
spermatids (n) – 23 chromosomes each made up of
one chromatid
6. spermiogenesis – development of spermatids into
a sperm cell
– spherical spermatids transform into elongated
sperm containing an acrosome and bearing a
flagellum
as the spermatogenic cells form through meiosis they
fail to undergho complete cytokinesis
– cells remain in contact throughout meiosis via
cytoplasmic bridges
– accounts for the synchronization observed in
the production of sperm in any given area of
the seminiferous tubule
Sperm
• 300 million made each day
• 60 um long
• major parts
– 1. head: contains the nucleus with 23 highly
condensed chromosomes (one chromatid)
– 2. acrosome: covers the anterior 2/3 of the head
• contains digestive enzymes to dissolve the
protective barriers of the egg (hyaluronidase and
proteases)
– 3. tail or flagellum
• neck - constricted region just behind the head
– contains centrioles for the production of the
microtubules for the tail
• middle piece – contains mitochondria arranged
in a spiral
• principal piece – longest portion of the tail
• end piece – terminal portion of the tail
-release of gonadotropic releasing hormone (GnRH) from the neurosecretory cells of
the hypothalamus which stimulates the gonadotrophs of the anterior pituitary gland
-anterior pituitary releases gonadotropins (FSH and LH)
1.
Follicle stimulating hormone - stimulates spermatogenesis
-synergistic action by FSH and testosterone on the Sertoli cells – secrete androgen-binding protein
into the lumen of the seminiferous tubule
-ABP binds to testosterone and keeps the concentration of this androgen high within the ST
-testosterone stimulates the final stages of spermatogenesis
-FSH release is inhibited by the release of inhibin by the Sertoli cells
2. Leutinizing hormone - stimulates male hormone production by the Leydig cells
-testosterone synthesized from cholesterol in the testes
-suppresses GnRH synthesis by negative feedback
-in some targets (e.g. prostate), testosterone is converted into dihydrotestosterone (DHT)
Testosterone
•
testosterone and DHT both bind to same receptors
–
•
•
receptors are found within the nuclei of the target cells
targets – bone, muscle
effects
– 1. prenatal development
• stimulates the male pattern of the reproductive system
–
gonads develop during the 5th week of gestation from two sets of ducts: 1) Wolffian ducts (males) and 2)
Mullerian ducts (females)
– therefore the embryo has the potential to develop into either sex
– BUT “maleness” determined by a gene called SRY – sex determining region of the Y chromosome
– SRY protein expression induces differentiation of Sertoli cells
– Sertoli cells secrete anti-Mullerian Hormone– apoptosis within the Mullerian ducts which inhibits the
development of female structures
-in response to hCG – Leydig cells begin to synthesize testosterone
-testosterone stimulates development of the epididymus, vas deferens, ejaculatory duct and seminal vesicle
• DHT stimulates development of external genitalia
–
–
–
–
development around the 8th week
from the genital tubercle (both males and females) – comprised of a urethral groove and two labiosacral swellings
elongation of part of the genital tubercle into the penis
labiosacral swellings - scrotum
• testosterone is converted in the brain to estrogens – development of certain brain regions in males
– 2. development of male sexual characteristics
– 3. development of sexual function
• male sexual behavior
• spermatogenesis
• libido in both males and females
–
females – androgen release by the adrenal cortex
– 4. stimulation of anabolism
• stimulate protein synthesis
Testosterone
Medical application: Anabolic steroids
•
•
•
•
•
•
•
•
•
a class of natural and synthetic steroid hormones
first discovered in the early 1930s
promote cell growth and division, protein sythesis (anabolism)
results in growth of several types of tissues, especially muscle and bone
increases bone remodelling and growth, increases bone marrow production of RBCs
increases size of clitoris or penis, increase vocal cord thickness, increases the libido, inhibits
spermatogenesis
different anabolic androgenic steroids have varying combinations of androgenic and anabolic
properties, and are often referred to in medical texts as AAS (anabolic/androgenic steroids)
for reversal of chronic wasting conditions including cancer and AIDS
stimulation of myogenesis
–
–
–
–
•
•
•
•
•
hypertrophy of both types of muscle fibers (I and II)
mechanism of this is not completely understood
increased synthesis of muscle proteins and/or decrease degradation of muscle proteins
also – increased commitment of muscle stem cells to the myogenic lineage and inhibiting their differentiation
to the adipogenic
supraphysiological doses of testosterone in men promotes nitrogen density and increases fat free mass
(skeletal muscle mass) while at the same time decreasing fat, particularly abdominal fat.
may also play an anticatabolic role in inhibiting skeletal muscle atrophy through inhibiting
glucocorticoid action
mechanisms of action differ depending on the specific anabolic steroid
different types of anabolic steroids bind to the androgen receptor to varying degrees depending on
their chemical makeup
also associated with numerous side effects when administered in excessive doses
–
increased LDL and decreased HDL, increased acne, elevated blood pressure, hepatotoxicity, and alterations in
left ventricle morphology.
Medical application:
Anabolic steroids
•
e.g. methandrostenolone (Dianabol) do not react strongly with the androgen receptor – stimulates
protein synthesis independently
–
–
–
–
–
–
–
–
–
–
–
–
–
–
•
•
•
•
•
1956, oral
aid to muscle growth by bodybuilders (Arnold Schwarzenegger)
continues to be produced in countries such as Mexico under the trade name Reforvit-b, Russia, Thailand, and US
black market.
relies on activity not mediated by the androgen receptor for its effects
includes dramatic increases in protein synthesis, glycogenolysis, and muscle strength
decreases the rate of cell respiration and decreases production of red blood cells - anemia
high doses (30 mg or more per day) - side effects such as gynaecomastia, high blood pressure, acne and male
pattern baldness may be seen
causes severe masculinising effects in women even at low doses
metabolized into estradiol - without the administration of inhibitors (e.g. Tamoxifen) estrogenizing effects will
appear
stacked (combined) with drugs that react strongly with the androgen receptor, such as Oxandrolone
processing of the steroid in the body decreases its ffinity for sex hormone binding globulin - protein that deactivates steroid molecules
significantly more active than an equivalent quantity of testosterone
BUT the concomitant elevation in estrogen levels results in significant water retention.
it is often used by bodybuilders only at the start of a "steroid cycle", to facilitate rapid strength increases
e.g. oxandrolone (Anvral, Oxandrin) binds the androgen receptor to mediate its effects
-oral, Class II steroid
-1964
-treatment of osteoporosis, alcohol hepatitis, Turner’s syndrome (XO), HIV wasting, anemia
-used frequently by bodybuilders – not easily metabolized into DHT or estrogens
Medical application:
Anabolic steroids
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Testosterone (attached to various esters enanthate, cypionate, propinate or suspended in
oil or water)
Methandrostenolone / methandienone (Dianabol)
Nandrolone Decanoate (Deca-durabolin)
Nandrolone Phenylpropionate (Durabolin)
Boldenone Undecylenate (Equipoise)
Stanozolol (Winstrol)
Oxymetholone (Anadrol-50)
Oxandrolone (Anavar)
Fluoxymesterone (Halotestin)
Trenbolone (Fina)
Methenolone Enanthate (Primobolan)
4-chlordehydromethyltestosterone (Turinabol)
Mesterolone (Proviron)
Mibolerone (Cheque Drops)
common misconceptions
–
–
–
–
–
shrinks the penis – actually decreases LH and FSH which affects the size of the testes
causes cancer – no linkage
cause suicide – no linkage
“roid rage” and aggression – no linkage
http://en.wikipedia.org/wiki/Anabolic_steroids
-pressure generated by the Sertoli cells pushes the sperm into a
series of ducts within the testes that end up as the epididymis
-within the epididymis is the ductus epididymis
-also made up of a head, body and tail portion
-site of sperm maturation – acquire mobility (14 days)
-helps propel sperm into the:
-vas (ductus) deferens: conducting tube from testis to urethra
-connects to the tail of the epididymis
-connects the testes to the urethra
-made up of a pseudostratified columnar epithelium with
a lamina propria connective tissue plus three layers of
smooth muscle
-contractions of these muscular layers propel the sperm
Reproductive Ducts
-spermatic cord supports the
vas deferens + blood vessels
(testicular artery and the
pampiniform venous plexus),
lymphatic vessels, the cremaster
muscle and autonomic nerves
-passes through the inguinal canal
• ejaculatory duct – forms from the union of the seminal
vesicle and the end of the vas deferens
– pass through the prostate gland and terminate in the urethra
• urethra: 3 sections:
•
A. prostatic - runs through the prostate
• connects to ducts from the prostate and to the ejaculatory duct
•
B. membranous - between prostate and penis
• -through the muscles of the perineum – urogenital diaphragm
•
C. spongy - through the erectile tissue of the penis
Male reproductive
glands
•
•
•
•
•
•
•
•
•
•
-glands: seminal vesicles, prostate, bulbourethral glands
-produce fluid that combine with sperm to make semen
-semen: alkaline, activates sperm cells
1. prostate: surrounds the urethra
-forms as an outgrowth of the urethra along with the
bulbourethral glands
-secretes a thin, milky fluid that enhances sperm motility
and neutralizes vaginal fluid
2. seminal vesicles: connect to urethra via the ejaculatory ducts
-secretes an alkaline fluid that contains sugars and
prostaglandins (stimulates uterine contractions)
3. bulbourethral glands: 2 glands behind
the prostate
-secrete a fluid that lubricates the penis
-conveys urine and semen
-body is found externally
-body is comprised of two tissue types of erectile tissue
surrounded by connective tissue
A. corpus cavernosum - large spaces
B. corpus spongiosum - smaller spaces
-surrounds the urethra
-root of the penis is attached to the pelvis
-corpus spongiosum enlargens at the tip - glans penis (sensory receptors)
-glans penis covered with a loose fold of skin = prepuce
-ovary: production of egg
-surface is covered with a germinal epithelium (simple epithelium) – does NOT give rise
to the ova!
-next layer is = tunica albuginea – dense irregular connective tissue capsule
-outer cortex- granular tissue due to the presence of tiny ovarian follicles
- inner medulla - connective tissue with blood & lymphatic vessels and nerves
Oogenesis and Follicular
Development
•
•
•
begins before birth
early fetal development – primordial germ cells from the yolk sac
migrate into the developing ovaries
differentiate to form oogonia (diploid stem cells)
–
•
•
undergo mitosis to produce millions of germ cells
most of the germ cells degenerate by atresia
a few develop further into primary oocytes – entered prophase I of
meiosis
–
–
–
–
–
surrounded by a layer of follicular cells = primordial follicle
continue to develop into primary follicles
at birth – 200,000 to 2,000,000 follicles within the ovary
at puberty 40,000 are still present
400 will develop further (rest undergo atresia)
-release of FSH and LH each month causes the development of one primary oocyte into a secondary oocyte
-development of a few primordial follicles into primary follicles (only one will continue until ovulation)
-primary follicle – primary oocyte surrounded by several layers of epithelial cells called granulosa cells
-develops a clear glycoprotein layer between the oocyte and the granulosa cells – zona pellucida
-the outermost granulosa cells contact a basement membrane which begins to develop into two layers (theca layers)
-now known as the secondary follicle
-secondary follicle begins to accumulate fluid in the center of the follicle (antrum)
-innermost granulosa cells firmly attaches to the zona pellucida = corona radiata
-becomes larger and turns into the tertiary or mature Graafian follicle
-completes meiosis I – two haploid cells
-these haploid cells are uneven in size but each have 23 chromosomes (two chromatids each - 46)
-smaller cell – first polar body (discarded nuclear material)
-larger cell – secondary oocyte
-receives most of the cytoplasm and has 23 chromosomes
-stops at metaphase II
-ovulated
Oogenesis and Follicular
Development
• ovulation – expulsion of the secondary
oocyte into the pelvic cavity with the
first polar body and corona radiata
• fertilization – union of egg and sperm
– penetration of the sperm into the
secondary oocyte results in the
resumption of meiosis II
– the secondary oocyte splits again into
two cells of unequal size (n)
– larger one is called the ovum and the
smaller one is the second polar body
– combination of the ovum and the sperm
results in the formation of the zygote
– the first polar body splits also into two
haploid cells
– therefore meiosis of the primary oocyte
produces one haploid ovum and three
haploid polar bodies that degenerate
• uterus: receives and nourishes the embryo
•
-comprised of a body, a curved portion (fundus) and the cervix
•
•
•
-uterine wall outer perimetrium, muscular myometrium and
inner endometrium
-endometrium: mucosal layer covered with epithelium
-rich blood supply, sloughed off during menstruation
• uterine tubes (Fallopian tubes): conduction of egg from ovary to
uterus
•
-expands at end near the ovary = infundibulum with fimbrae (fingers) for the
•
“catching” of the released egg
-lined with a mucosal layer and columnar epithelium with cilia
-are also cells with microvilli rather than cilia – produce a nutritive fluid for the
egg
• cervix: projects into the vaginal canal
Female Reproductive Cycle
• two cycles
– 1. ovarian: during and after the maturation of
the oocyte
– 2. uterine: concurrent series of changes in the
endometrium of the uterus to prepare it for
embryo implantation
-3 major types of estrogens:
1.
beta-estradiol
2.
estrone
3.
estriol
4.
other smaller quantities
-follicular estrogens:
a.
promote the development of the
female reproductive structures,
secondary sex characteristics and
the mammary glands
b. increase protein anabolism, including
bone synthesis
c. lower blood cholesterol
d. inhibit the release of GnRH, FSH
and LH
-GnRH causes release of FSH and LH from anterior pituitary
-FSH initiates follicular growth
-LH stimulates the maturation of follicles
-both LH and FSH stimulate the secretion of estrogens from the follicle
-LH stimulates the theca layers of the follicle to make androgens
-FSH stimulates the uptake of these androgens and converts them to estrogens
-LH triggers ovulation and results in development of corpus luteum
-corpus luteum produces and releases progesterone and some estrogen plus relaxin and inhibin
-estrogen and progesterone regulate pregnancy, menstruation, secondary sex char’s
& development of sex organs at puberty
-relaxin – relaxes the uterus by inhibiting contractions of the myometrium
-important to the implantation of the embryo – produced by the placenta during pregnancy
-also increases the flexibility of the pubic symphysis
-inhibin - inhibits secretion of FSH and LH
1.
Menstrual Phase
A. Ovarian events – FSH
increase causes development
of primordial follicles into
primary follicles
B. Uterine events – 50-150 mL
of blood, tissue fluid, mucus
and epithelial cells
-shed from the stratum
functionalis
-occurs because of declining levels
of E and P – loss of stratum
functionalis
- leaving the stratum basalis intact
2. Preovulatory Phase – most variable in
length
A. Ovarian events – secretion of E
and inhibin from the secondary
follicles
-one secondary follicle outgrows the
rest to become the dominant follicle
-the dominant follicle secretes E and I
which causes an inhibition of FSH and
a decrease in the stimulation of other
follicles
-the dominant follicle develops into
the Graafian follicle
-forms a blister-like bulge due to an
increase in fluid within the antrum of
the follicle
-the GF continues to increase its
estrogen production
B. Uterine events – E stimulates the
repair of the SF – growth from the
stratum basalis
-increase in arteriole size and blood
supply
• 3. Ovulation
•
A. Ovarian events – rupture
of the GF usually around day 14
• ovulated secondary follicle
remains surrounded by its
corona radiata and its zone
pellucida
• triggered by a positive feedback
system – high levels of E at the
end of the preovulatory phase
increases the secretion of GnRH,
which then increases the release
of LH
• increased LH induces rupture of
the GF about 9 hours after the LH
peak
• basis for the at-home ovulatory
tests – detect rises in LH
•
B. Uterine events - none
• signs of ovulation
–
–
–
–
Increase in basal body temperature
Changes in cervical mucus
Cervix softens
Mittelschmerz---pain
• 4. Postovulatory Phase – most consistent part of the cycle (14
days)
– A. Ovarian events – the mature graafian follicle collapses and bleeds
- the development of a blood clot results as the follicle induces bleeding – follicle is
now called the corpus hemorrhagicum
• granulosa and thecal cells come into direct contact – follicle is transformed into
corpus luteum cells under the influence of LH
• luteal cells produce hormones - progesterone, estrogen, relaxin and inhibin
–
Progesterone and estrogen are now –ve feedback signals for inhibition of GnRH – together with inhibin
• if the ovum is NOT fertilized, the CL degenerates into the corpus albicans – 2
weeks
• Resulting decrease in P, E and Inhibin results in the release of GnRH, FSH
and LH (loss of negative feedback) - new follicular growth begins
• if fertilized – the CL persists beyond 2 weeks by the secretion of human chorionic
gonadotropin (hCG) hormone produced by the developing chorion that surrounds
the embryo (8 days post-fertilization)
GnRH release
Stratum functionalis
B. Uterine events – P and E produced by the corpus luteum
promotes the growth and vascularization of the endometrium and
its thickening to about 12-18 mm
-endometrial glands within the endometrium begin to secrete glycogen –
energy for the fertilized egg
Summary
Birth Control Methods
•
•
•
•
•
Surgical
Hormonal
Mechanical barriers
Periodic abstinence
Coitus interruptus
Reproductive disorders
•
Males
–
–
–
–
•
Females
–
–
–
–
–
–
•
testicular cancer
prostate concer
erectile dysfunction (ED)
benign prostatic hyperplasia
PMS
PMDD
Endometriosis
Ovarian, uterine cysts
Ovarian, uterine, cervical cancer
vulvovaginal candidiasis
Both
– UTI
– STDs – gonorrhea, syphillis, chlamydia, genital herpes, genital warts
Pregnancy
-fertilization in the upper third of the oviduct/fallopian tube
-fertilization = union of egg and sperm
-plasma membrane of the egg is surrounded by an extracellular matrix = zona pellucida
and a ring of follicular cells = corona radiata (nourishment in the follicle)
-after fertilization = zygote
1. sperm penetrates corona radiata
2. several sperm enter zona pellucida
-one of the glycoproteins within the ZP
(ZP3) acts as a receptor for the sperm
-binding causes dissolution of the acrosome
and release of digestive enzymes
3. ONE sperm penetrates the plasma
membrane of the egg
4. immediate change in the oocyte cell
membrane (depolarizes)
-also binding results in release of intracellular
calcium which stimulates exocytosis of
secretory vesicles whose contents inactivate
ZP3 and harden the zona pellucida
- impervious to more sperm
5. oocyte releases the zona pellucida
away from the egg surface
6. fusion of the sperm with nucleus of
the egg
-before fusion the secondary oocyte must complete
meiosis II and form the ovum
embryonic stage:
week 2 to week 8
-after sperm penetration and ovum development the nuclei of the egg and sperm
undergo changes to become pronuclei
-union of sperm and egg pronuclei nuclei forms the zygote
-first cell division = embryo
-first division takes place 24 hours post-fertilization – takes 6 hours to complete
-each succeeding division takes less time
-72 hr stage = 16 cells
-96 hr stage = morula (embryo is the size of the original ovum, filled with cells (blastomeres)
Implantation
• attaches after about 6
days
• usually in the fundus or
the body of the uterus
• orients its inner cell
mass toward the uterus
• 7 day – the endometrium
becomes more
vascularized
• 9 days – completely
embedded
• following implantation,
the endometrium is
called the decidua
– several layers with
defined functions
-day 4 – formation of morula and passage into the uterine cavity
-endometrial glands release a glycogen-rich fluid = uterine milk
-enters the morula through the zona pellucida and provides nourishment
-day 5 -the fluid begins to collect in the morula and reorganizes them around a fluid-filled
cavity = blastocoel
-embryo is now called a blastula or blastocyst (50-150 cells)
-outer layer = trophoblast - forms extraembryonic tissues (e.g. placenta,
yolk sac)
-inner cell mass at one end - totipotent embryonic stem cells
-by the end of day 5, the blastocyst digests a hole in the ZP and squeezes through it
to undergo implantation
-second week of development - the inner cell mass flattens = embryonic disk (hypoblast and epiblast)
-hypoblast = primitive endoderm
-epiblast = primitive ectoderm
-amniotic cavity forms between the inner cell mass and the trophoblast
-surrounded by an amniotic membrane – develops from the epiblast
-fills with amniotic fluid – filtrate from maternal blood at initial stages
-formation of the yolk sac (from the hypoblast)
-forms blood cells, gives rise to sex cells and the stem cells of the immune system
-also forms part of the embryonic digestive tube
-portion will also become part of the umbilical cord
-the outer trophoblast cells develops into two layers within the region where the blastocyst and
the endometrium make contact – become part of the chorion
-these trophoblast cells will secrete digestive enzymes that allow the embryo to
burrow into the decidua
-also secrete hCG – rescues the corpus luteum from degeneration
• day 15: embryonic disk undergoes gastrulation to form the gastrula
embryonic stage
– formation of the three embryonic germ layers by differentiation of the ES cells
within the embryonic disc
• epiblast form a specialized region = primitive streak
–
–
–
–
–
clearly establishes a head and tail orientation
head end the streak enlargens to form the primitive node
cells from the epiblast move inward through the primitive streak
some cells displace the hypoblast and form the endoderm
other cells are retained in the area and form the mesoderm
• mesoderma forms a loose connective tissue = mesenchyme
– cells remaining in the epiblast form the ectoderm
-portions of the mesoderm that
do not form the notochord
segment into sections called
somites -> specific body
regions and structures
-in front of the primitive streak forms the primitive node – head and associated structures
-mesodermal cells from the primitive node form a hollow tube near the future head of the
embryo - become the notochord (day 22-24)
(progenitor to the vertebral column)
-four weeks of development - embryo forms a tubular structure
-embryo begins to form definitive structures:
-neural folds of ectoderm -> nervous system (brain and spinal cord)
** neurulation occurs by induction (one tissue influences the development of another)
-e.g. nervous system requires the mesodermal cells of the notochord
Medical application: Stem Cells
• two broad categories of mammalian stem cells exist:
embryonic stem cells, and adult stem cells
• Stem cells = primal cells that:
– 1) retain the ability to renew themselves through cell division and
2) can differentiate into a wide range of specialized cell types
• stem cell field grew out of findings by Canadian
scientists Ernest A. McCulloch and James E. Till in the
1960s
– 1963 – self-renewing cells in the bone marrow of mice
• 1964 - single cells from a human testicular teratocarcinoma
were isolated
– - remained undifferentiated in culture = embryonic carcinoma
cells (EC cells)
• 1968 – bone marrow transplant was used to cure two
patients of SCID
• 1978 – Hematopoietic Stem Cells (HSCs) were isolated
from the bone marrow and identified
• 1981 – Embryonic stem cells (ES cells) first isolated and
cultured from mouse embryos in 1981 by two independent
research groups. Evans and Kaufman, Martin
• 1998 - human embryonic stem cells isolated and grown by
James Thomson at the University of Wisconsin-Madison
– developed a technique to isolate and grow ES cells from human
blastocysts
• stem cells can be defined by their ability to form specific cell types
• potency = ability to specialize into a distinct cell type
•
-unipotent – ability to form only one cell type
•
e.g. pre-adipocyte -> adipocyte
– sometimes called progenitor cells because of their limited ability to specialize
•
•
•
-bipotent – ability to form two cell types
e.g. osteochondro progenitor cells (OPCs) – bone and cartilage
-multipotent/pluripotent – ability to form many cell types
• multipotent – usually within one germ lineage (mesoderm)
•
e.g. MSC & ASCs – bone, fat, cartilage and muscle
• pluripotent – within more than one lineage (mesoderm & ectoderm)
•
•
•
-adult stem cells????
-totipotent – ability to form all cell types
e.g. ES cell
•
adult stem cell populations
–
–
–
–
–
–
–
–
–
–
•
•
•
fetal stem cell populations – placental and fetal tissue derived
-placental & amniotic populations
-umbilical cord blood
–
•
increased potentials because of their “younger” age???
adult stem cells may have limited potency when compared to ES cells
–
•
•
•
•
•
bone marrow – HSC and MSC
adipose – ASC
skin
brain/neural - NSCs
skeletal muscle
mammary
olfactory
hepatic
corneal
etc…….
but are still useful because of their limited ethical concerns
in addition ES cells still may possess the ability to form cancers
-many proto-oncogenes are involved in embryonic and fetal development
-these genes turn on and off at specific times during development
-if they turn back on during adult stages = oncogenes – may cause the formation of tumors
http://stemcells.nih.gov/
Use of adult stem cells
•
•
•
•
•
use of bone marrow stem cells (i.e. HSCs) leukemia and lymphoma
Potential treatments
2.1 Brain Damage
neural stem cells
rats subjected to stroke - administration of drugs to increase the NSC division rate and may increase the survival and differentiation of
newly formed cells
•
several studies in which NSCs or ES cells are injected into damaged areas of the brain
•
•
•
2.2 Cancer
2.3 Spinal cord injury
University of Wisconsin-Madison: differentiated human blastocyst stem cells into neural stem cells, then into the beginnings of motor
neurons, and finally into spinal motor neuron cells
University of California: injection of hES cells into paralyzed mice – limited regaining of their ability to move and walk four months
later.
–
–
•
–
–
•
•
•
•
treatment for Parkinson’s
stem cells regenerated neurons in addition to the myelin sheath
http://img227.imageshack.us/img227/7954/stemcellbreakthru052wl.jpg
2.4 Muscle damage - use in muscular dystrophy and myasthenia gravis
2.5 Heart damage – repair of ischemic coronary arteries
2.6 Low blood supply
2.7 Baldness
–
–
•
•
•
•
within weeks, recovery of brain structure is accompanied by recovery of lost limb function
stem cells within hair follicles
follicle stem cells may lead to successes in treating baldness through "hair multiplication," also known as "hair cloning," as early as 2008????
2.8 Missing teeth
2.9 Deafness
2.10 Blindness and Vision Impairment
2.11 ALS (Lou Gehrig's Disease)
–
–
–
–
–
Johns Hopkins University: induced nerve damage similar to that of ALS
injection of rats with stem cells - migration to the sites of injury
regeneration of the dead nerve cells
restoration of movement
(http://www.cellmedicine.com/als.asp)
Therapeutic cloning
•
•
•
•
•
•
In somatic cell nuclear transfer (SCNT) the nucleus of a somatic cell is removed and
the rest of the cell is discarded.
the nucleus of an egg cell is removed
the nucleus of the somatic cell is then inserted into the enucleated egg cell.
the egg is stimulated to divide by an electric shock (depolarizes the egg’s plasma
membrane)
new cell begins to divide and proceedes through the various embryonic stages
SCNT is used in stem cell research - to obtain stem cells that are genetically matched to
the donor organism
–
–
•
e.g. potential use of genetically-customized stem cells & Parkinson's disease - stem cells
resulting from SCNT would those genes that contribute to Parkinson's disease. therefore, the
disease-specific stem cell lines could be studied in order to better understand the disease
e.g. genetically-customized stem cell lines could be generated for cell-based therapies to
transplant to the patient - avoiding any complications from immune system rejection
*** no human stem cell lines have been derived from SCNT research. In 2005, a South
Korean research team led by Professor Hwang Woo-suk, published claims to have
derived stem cell lines via SCNT ,but supported those claims with fabricated data
Cloning types
•
Molecular cloning
–
–
–
–
•
procedure of isolating a DNA sequence of interest and obtaining multiple copies of it in an
organism.
frequently employed to amplify DNA fragments containing genes, an essential step in their
subsequent analysis.
cloning of any DNA sequence involves the following four steps:
fragmentation, ligation, transfection, and screening/selection.
Genetic cloning
– Cloning a cell means to derive a (clonal) population of cells from a single cell.
Asexual reproduction (also known as agamogenesis) is a form of reproduction
which does not involve meiosis, gamete formation, or fertilization.
– In laymen's terms, there is only one "parent" involved.
– common among simple organisms such as amoeba and other single-celled
organisms,
Horticultural
-clone in horticulture means all descendants of a single plant, produced by vegetative reproduction
-many horticultural plant cultivars are clones - multiplied by some process other than sexual
reproduction.
e.g. some European grapes represent clones that have been propagated for over two
millennia.
other examples are potato and banana.
-Grafting can be regarded as cloning, since all the shoots and branches coming from the graft are
genetically a clone of a single individual
-Many trees, shrubs, vines, ferns and other herbaceous perennials form clonal colonies.
Reproductive Cloning
•
•
•
SCNT can also be used in the reproductive cloning of animals (e.g. Dolly the sheep), and in theory could be used to
clone humans.
embyro is created by SCNT & transferred to the uterus of a female host where it continues to develop until birth
Dolly or any other animal created using nuclear transfer technology is not truly an identical clone of the donor animal.
–
–
–
–
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Only the clone's chromosomal or nuclear DNA is the same as the donor.
the mitochondrial DNA will differ
mutations will occur throughout embryonic and fetal development
so the clone is not 100% identical!
Species cloned
Tadpole: (1952) Many scientists questioned whether cloning had actually occurred and unpublished
experiments by other labs were not able to reproduce the reported results.
Carp: (1963) In China, embryologist Tong Dizhou cloned a fish. He published the findings in an
obscure Chinese science journal which was never translated into English.[1]
Mice: (1986) first successfully cloned mammal; Soviet scientists Chaylakhyan, Veprencev,
Sviridova, Nikitin had mice "Masha" cloned.
Sheep: (1996) from early embryonic cells by Steen Willadsen. Megan and Morag cloned from
differentiated embryonic cells in June 1995 and Dolly the sheep in 1997.
Rhesus Monkey: Tetra (female, January 2000) from embryo splitting
Cattle: Alpha and Beta (males, 2001) and (2005) Brazil
Cat: CopyCat "CC" (female, late 2001), Little Nicky, 2004, first cat cloned for commercial reasons
Mule (2004): Idaho Gem, a john mule - the first horse-family clone.
(2003) Horse: Prometea
a similar process called budding has been used in cattle for decades
-an embryo is dissociated into individual cells without harm
-each cell – separate embryo
-animal is not derived from a differentiated cell but from a undifferentiated egg
HIV and AIDS
-most viral illnesses are caused by DNA viruses
a. binding of virus to host cells via interaction of host and viral envelope proteins - endocytosis
b. degradation of viral capsid proteins to release the naked viral DNA
c. viral DNA enters host nucleus and “takes over” host machinery d. replication, transcription and translation of viral components
e. assembly of new viral capsids and
formation of new viral progeny
f. release of progeny from host cell
(cell death of host)
HIV
•
Previous names:
–
–
–
•
•
Infection - transfer of blood, semen, vaginal fluid, pre-ejaculate or breast milk.
HIV is present as both free virus particles and virus within infected immune cells. three major
routes of transmission:
–
–
–
•
•
•
e.g. helper T cells (specifically CD4+ T cells), macrophages and dendritic cells
infection leads to low levels of CD4+ T cells through three main mechanisms:
–
–
–
•
unprotected sexual intercourse
contaminated needles and
transmission from an infected mother to her baby HIV primarily infects vital cells of the immune system
HIV primarily infects vital cells of the immune system
–
•
human T-lymphotropic virus-III (HTLV-III)
lymphadenopathy-associated virus (LAV)
AIDS-associated retrovirus (ARV)
1. direct viral killing of infected cells
2. increased rates of apoptosis in infected cells
3. killing of infected CD4+ T cells by CD8 cytotoxic lymphocytes – recognize infected cells.
when CD4+ T cell numbers decline below a critical level – loss of cell-mediated immunity (T
cell mediated immunity)
body becomes progressively more susceptible to opportunistic infections.
about one in ten remain healthy for many years, with no noticeable symptoms
HIV timeline
•
•
•
•
•
•
•
•
•
•
•
•
•
•
AIDS epidemic was discovered June 5, 1981
U.S. Centers for Disease Control and Prevention reported a cluster of
Pneumocystis carinii pneumonia in five homosexual men in Los Angeles
originally dubbed GRID, or Gay-Related Immune Deficiency
1982 - the CDC introduced the term AIDS
1983 - scientists led by Luc Montagnier at the Pasteur Institute in France
discovered the HIV
originally called lymphadenopathy-associated virus (LAV).
1984 - a team led by Robert Gallo of the US confirmed the discovery of the
virus
renamed it human T lymphotropic virus type III (HTLV-III)
President Mitterrand and President Reagan had to resolve the discovery issues
1986 - renamed human immunodeficiency virus (HIV)
Three of the earliest known instances of HIV-1 infection are as follows:
1. A plasma sample taken in 1959 from an adult male living in what is now the
Democratic Republic of Congo
2. HIV found in tissue samples from a 15 year old African-American teenager
who died in St. Louis in 1969
3. IV found in tissue samples from a Norwegian sailor who died around 1976
HIV classification
•
•
•
•
HIV classified as a member of the genus lentivirus - part of the family of
retroviridae Lentiviruses: responsible for long-duration illnesses, long
incubation period
transmitted as single-stranded, positive-sense, enveloped RNA virus
upon entry of the target cell, the viral RNA genome is converted to doublestranded DNA by a virally encoded reverse transcriptase
viral DNA is then integrated into the cellular DNA by a virally encoded
integrase after cell infection - two pathways are possible:
– 1. either the virus becomes latent and the infected cell continues to function
– 2. the virus becomes active and replicates – produces a large number of progeny
viruse particles
•
•
Two species of HIV infect humans: HIV-1 and HIV-2.
HIV-1 is thought to have originated in southern Cameroon after jumping from
wild chimpanzees (Pan troglodytes troglodytes) to humans
–
–
–
–
•
HIV-1 is more virulent.
easily transmitted
is the cause of the majority of HIV infections globally.
HIV-1 is the virus that was initially discovered and termed LAV.
HIV-2 may have originated from the Sooty Mangabey (Cercocebus atys), an
Old World monkey of Guinea-Bissau, Gabon, and Cameroon
– HIV-2 is less transmittable
– largely confined to West Africa
Structure and genome
•
•
•
•
•
•
•
HIV is different in structure from other retroviruses.
approximately 120 nm in diameter (around 60 times smaller than a red blood cell) roughly spherical.
composed of two copies of positive single-stranded RNA
RNA codes for the virus's nine genes – but it must be converted back into DNA (reverse transcribed by an enzyme called reverse
transcriptase)
enclosed by a conical capsid composed of 2,000 copies of the viral protein p24
single-stranded RNA is tightly bound to: nucleocapsid proteins, p7 and enzymes needed for the development of the virion such as reverse
transcriptase, proteases, ribonuclease and integrase
the capsid is surrounded by a matrix composed of the viral protein p17
–
•
•
•
•
•
ensures the integrity of the virion particle
matrix is surrounded by a viral envelope - two layers phospholipids taken from the membrane of a human cell upon budding of the
progeny virsus from its host
viral envelope is embedded with proteins from the host cell and about 70 copies of a complex HIV protein called Env
Env - cap made of three molecules called glycoprotein (gp) 120, and a stem consisting of three gp41 molecules (anchor the Env complex
to the viral envelope)
– enables the virus to attach to and fuse with target cells
– both gp120 and gp41 (especially gp120) are targets of future treatments or vaccines
3 genes = gag, pol, and env contain information needed to make the structural proteins for new virus particles
– 1. env - codes for gp160 which is processed to form gp120 and gp41
– that is broken down by a viral enzyme to form gp120 and gp41
– 2. gag – codes for the capsid protein 024, the nucleocapsid proteins p6, p7 and the matrix protein p17
– 3. pol – codes for the enzymes reverse transcriptase, integrase and protease
the six remaining genes are tat, rev, nef, vif, vpr, and vpu (or vpx in the case of HIV-2) - are regulatory genes that code for proteins that
control the ability of HIV to infect cells, replicate, or cause disease
– e.g. nef appears necessary for the virus to replicate efficiently, and the
– e.g. vpu influences the release of new virus particles
HIV Tropism
•
•
•
viral tropism = cell types HIV infects.
HIV infects a variety of immune cells such as CD4+ T cells, macrophages, and microglial cells
HIV-1 entry to macrophages and CD4+ T cells is mediated through interaction of gp120 with:
–
–
•
•
•
1. the CD4 molecule
2. with chemokine coreceptors
Strains of HIV-1
1. Macrophage (M-tropic) or non-syncitia-inducing strains (NSI)
– use the β-chemokine receptor CCR5 for entry
– able to replicate both in macrophages and CD4+ T cells
– CCR5 receptor is used by almost all primary HIV-1 isolates regardless of viral genetic subtype.
– macrophages appear to be the first cells infected by HIV
– perhaps the source of HIV production when CD4+ cells become depleted in the patient
– microglial cells in the CNS can be infected by the NSI strains
2. T-tropic isolates, or syncitia-inducing (SI) strains
– replicate in primary CD4+ T cells and macrophages
– use the α-chemokine receptor, CXCR4
– administration of SDF-1(a ligand for CXCR4) may be able to suppress replication of T-tropic
HIV-1 isolates by down-regulating the expression of CXCR4 on the surface of these cells
– HIV strains that use only the CCR5 receptor are termed R5
– those that only use CXCR4 are termed X4
– those that use both = X4R5
– Some people are resistant to certain strains of HIV
– e.g. people with a mutation in the CCR5 gene (CCR5-Δ32 mutation); these resistant to infection
with R5 virus - HIV cannot bind this coreceptor thus reducing its ability to infect target cells.
– Both X4 and R5 HIV are present in the seminal fluid which is passed from partner to partner
– R5 strain seems to predominate
– unknown why – but spermatozoa may selectively carry R5 HIV
– they possess both CCR3 and CCR5 but not CXCR4 on their surface
– genital epithelial cells preferentially infected by the X4 virus
•
•
•
•
•
•
•
•
HIV Replication
Entry to the cell
enters via adsorption of its glycoproteins on
its to receptors on the target cell
requires interactions between the envelope
protein complex Env (gp160 spike) + CD4 +
either CCR5 or CXCR4 (others CCRs are
known to interact!! )
gp160 spike contains binding domains for
both CD4 and chemokine receptors.
fusion results - involves the high-affinity
attachment of CD4 to gp120
this changes the shape of gp120 and allows in
now to intereact with the chemokine receptor
a more stable two-pronged attachment, allows
gp41 to penetrate the cell membrane and
allows subsequent entry of the viral capsid.
Once HIV has bound to the target cell, the
HIV RNA and various enzymes, including
reverse transcriptase, integrase, ribonuclease
and protease, are injected into the cell
HIV Replication
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
Replication and transcription
once inside the cell reverse transcriptase liberates the single-stranded
(+)RNA from the attached viral proteins and copies it into a
complementary DNA of 9 kb size
process of reverse transcription is extremely error-prone and it is during
this step that mutations may occur.
Such mutations may cause drug resistance
reverse transcriptase then makes another complementary DNA strand to
form a double-stranded viral DNA intermediate (vDNA).
This vDNA is then transported into the cell nucleus
integration of the viral DNA into the host cell's genome is carried out
by another viral enzyme called integrase
integrated viral DNA may then lie dormant = latent stage of infection
BUT to actively produce the virus, certain HOST cellular transcription
factors need to be present
these factors are upregulated when the T cell is fighting an infection
this means that those cells most likely to be infected and killed by HIV
are in fact those currently fighting infectio
during replication - the integrated provirus is copied to mRNA which
is then spliced into smaller pieces.
these small pieces produce the regulatory proteins Tat (which
encourages new virus production) and Rev (affects processing of the
mRNA to produce different viral proteins)
as Rev accumulates it gradually starts to inhibit mRNA splicing and
results in the production of the structural proteins Gag and Env from
the full-length mRNA.
the full-length RNA is actually the virus genome; it binds to the Gag
protein and is packaged into new virus particles.
HIV Replication
•
•
•
•
•
•
•
•
•
Assembly and release
final step of the viral cycle = assembly of new HIV-1 virions
begins at the plasma membrane of the host cell
the Env polyprotein (gp160) goes through the endoplasmic reticulum
and the Golgi complex of the host where it is processed into the two
HIV envelope glycoproteins gp41 and gp120.
these are transported to the plasma membrane of the host cell
Gag polyprotein (p55) associates with the inner surface of the plasma
membrane along with the HIV genomic RNA
during maturation, the HIV protein protease process or cleave the
proteins made by the host into individual functional HIV proteins and
enzymes.
cleavage step can be inhibited by protease inhibitors.
the various structural components then assemble to produce a mature
HIV virion
The clinical course of infection
•
•
stage of infection can be determined by measuring the patient's CD4+ T cell count, and the level of HIV in the blood
initial infection occurs after transfer of body fluids
•
the first stage of infection = the primary, or acute infection
–
–
–
–
–
–
–
–
–
•
clinical latency stage = strong immune defense reduces the number of viral particles in
–
–
–
–
–
–
–
–
–
–
–
•
a period of rapid viral replication
levels of HIV commonly approaching several million viruses per mL
accompanied by a marked drop in the numbers of circulating CD4+ T cells = acute viremia
also with the activation of CD8+ T cells - kill HIV-infected cells
antibody production
CD8+ T cell response is important in controlling virus levels
good CD8+ T cell response has been linked to slower disease progression and a better prognosis
during this period most individuals (80 to 90%) develop an influenza-like illness
often not recognized as a sign of HIV infection
marks the start of this phase
vary between two weeks and 20 years
HIV is active within lymphoid organs & surrounding tissues rich in CD4+ T cells may also become infected
viral particles accumulate both in infected cells and as free virus.
Individuals are still infectious.
CD4+ T cells carry most of the proviral load
when CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost - opportunistic
infections appear.
first symptoms include: moderate and unexplained weight loss, recurring respiratory tract infections and oral
ulcerations
oral Candida species and Mycobacterium tuberculosis - increased susceptibilty to oral candidiasis (thrush) and
tuberculosis.
reactivation of latent herpes viruses causes patients to suffer from shingles from Epstein-Barr virus-induced Bcell lymphomas, and from Kaposi's sarcoma (endothelial cell tumor)
Pneumonia caused by the fungus Pneumocystis jiroveci
final stages of infection = AIDS
–
infection with cytomegalovirus (another herpes virus) or Mycobacterium avium complex
Acute phase: CD4 T cell count drops from 800 to 500 per mm3 (normal immune fxn
possible)
-spike in viral load with initial infection
-massive replication of CD4 T cells to try and stay ahead of viral load
Chronic phase: T cell count is 200- 499
-appearance of symptoms - swollen lymph nodes, fatigue, cough, diarrhea
AIDS: T cell count is below 200
-degeneration of lymph nodes
-opportunistic infections - pneumonia, tuberculosis, encephalitis, Kaposi’s
sarcoma
Treatment
•
•
•
•
no vaccine (http://www.brown.edu/Courses/Bio_160/Projects1999/hiv/vacstrat.html)
prevention is avoiding exposure to the virus.
antiretroviral treatment - known as post-exposure prophylaxis reduces risk of infection
treatment for HIV infection = highly active antiretroviral therapy, or HAART
current HAART options - cocktails of least three drugs
–
–
•
•
•
•
•
•
Abacavar - a nucleoside analog reverse transcriptase inhibitors (NARTIs or NRTIs)
two types of anti-retroviral agents - nucleoside analogue reverse transcriptase inhibitors
(NARTIs or NRTIs)
plus either a protease inhibitor or a non-nucleoside reverse transcriptase inhibitor
(NNRTI).
more aggressive treatment is recommended for children
HAART allows the stabilisation of the patient’s symptoms and viremia,
computer based study in 2006 projected that following the 2004 United States treatment
guidelines gave an average life expectancy of an HIV infected individual to be 32.1
years from the time of infection if treatment was started when the CD4 count was
350/µL
absence of HAART - progression from HIV infection to AIDS has been observed to
occur at a median of between nine to ten years and the median survival time after
developing AIDS is only 9.2 months
HAART - effective in less than fifty percent of patients- intolerance/side effects, prior
ineffective antiretroviral therapy, infection with a drug-resistant strain of HIV, nonadherence and non-persistence with antiretroviral therapy (due to economics, social
structure or HAART complexity)
side effects include lipodystrophy, dyslipidaemia, insulin resistance, an increase in
cardiovascular risks and birth defects
Epidemiology
• UNAIDS and the WHO estimate that AIDS has killed more than
25 million people since it was first recognized in 1981
• 2005: AIDS pandemic claimed an estimated 2.8 million - of which
more than half a million (570,000) were children
• Globally, between 33.4 and 46 million people currently live with HIV
• 2005, between 3.4 and 6.2 million people were newly infected and
between 2.4 and 3.3 million people with AIDS died, an increase from
2004 and the highest number since 1981.
• worst affected = Sub-Saharan Africa - estimated 21.6 to 27.4 million
people HIV positive
– Two million [1.5–3.0 million] of them younger than 15 years of age.
– More than 64% of all people living with HIV are in sub-Saharan Africa,
• Including more than three quarters of all women living with HIV
– average life expectancy is 48.3 years
• South & South East Asia are second-worst affected with 15% of the
total.
– AIDS accounts for the deaths of 500,000 children in this region.
– Two-thirds of HIV/AIDS infections in Asia occur in India (the highest
number of HIV infections in the world)
• United States, the number of persons with AIDS increased from about
35,000 in 1988 to over 220,000 in 1996